- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
103
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
103 companies
Ascentage Pharma Group International
Market Cap: HK$24.0b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$65.25
7D
4.5%
1Y
59.9%
Pharma Mar
Market Cap: €1.3b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, China, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€75.65
7D
5.7%
1Y
3.0%
PharmaResearch
Market Cap: ₩4.8t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩460,000.00
7D
-7.2%
1Y
121.7%
Oscotec
Market Cap: ₩2.1t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩53,700.00
7D
18.0%
1Y
120.5%
RemeGen
Market Cap: HK$51.8b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$84.65
7D
0.6%
1Y
431.7%
ALTEOGEN
Market Cap: ₩29.3t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩548,000.00
7D
5.0%
1Y
34.5%
MedinCell
Market Cap: €1.0b
A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.
MEDCL
€30.32
7D
2.8%
1Y
81.3%
Bonesupport Holding
Market Cap: SEK 13.3b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 202.00
7D
-2.1%
1Y
-41.8%
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥12.4b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥39.22
7D
4.1%
1Y
3.6%
Neuland Laboratories
Market Cap: ₹222.7b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹17,356.10
7D
-4.2%
1Y
15.5%
Akeso
Market Cap: HK$107.0b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$116.20
7D
1.0%
1Y
81.8%
Egetis Therapeutics
Market Cap: SEK 2.3b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.87
7D
-4.9%
1Y
12.7%
EZZ Life Science Holdings
Market Cap: AU$114.2m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.
EZZ
AU$2.42
7D
1.7%
1Y
-14.2%
3billion
Market Cap: ₩376.9b
Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.
A394800
₩11,880.00
7D
21.6%
1Y
285.7%
Suzhou Zelgen Biopharmaceuticals
Market Cap: CN¥26.7b
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
688266
CN¥100.90
7D
1.7%
1Y
61.6%
Beijing Sun-Novo Pharmaceutical Research
Market Cap: CN¥6.5b
A contract research company, engages in the research and development of drugs in China.
688621
CN¥59.13
7D
4.7%
1Y
42.1%
Ocumension Therapeutics
Market Cap: HK$7.0b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$8.56
7D
-1.6%
1Y
62.7%
PharmaResources (Shanghai)
Market Cap: CN¥4.4b
Operates as a CRO, CDMO, and CMO service provider of drug discovery in China.
301230
CN¥31.72
7D
-2.3%
1Y
28.9%
Macrogen
Market Cap: ₩168.4b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩15,530.00
7D
3.6%
1Y
-3.8%
Aether Industries
Market Cap: ₹112.4b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹847.40
7D
14.8%
1Y
4.1%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥11.9b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥17.21
7D
-2.5%
1Y
6.7%
Clinuvel Pharmaceuticals
Market Cap: AU$558.2m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$11.12
7D
0.9%
1Y
-18.1%
Boji Medical TechnologyLtd
Market Cap: CN¥4.1b
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
300404
CN¥10.61
7D
4.6%
1Y
22.5%
Corcept Therapeutics
Market Cap: US$7.9b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$75.12
7D
-0.5%
1Y
42.8%
OS Therapies
Market Cap: US$60.4m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$1.71
7D
-11.9%
1Y
-17.0%
AprilBioLtd
Market Cap: ₩917.5b
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
A397030
₩39,950.00
7D
23.3%
1Y
115.9%
Precigen
Market Cap: US$1.7b
A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.
PGEN
US$4.90
7D
22.5%
1Y
518.5%
Aelis Farma
Market Cap: €14.8m
A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.
AELIS
€1.09
7D
-0.9%
1Y
-62.9%
Longeveron
Market Cap: US$14.5m
A clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.
LGVN
US$0.65
7D
-12.5%
1Y
-66.4%
Eton Pharmaceuticals
Market Cap: US$454.3m
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$17.26
7D
2.0%
1Y
72.1%
Shanghai Rightongene Biotechnology
Market Cap: CN¥1.6b
Shanghai Rightongene Biotechnology Co., Ltd.
688217
CN¥29.18
7D
0.1%
1Y
45.7%
Caliway Biopharmaceuticals
Market Cap: NT$194.7b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$125.50
7D
-3.1%
1Y
146.1%
Senores Pharmaceuticals
Market Cap: ₹36.3b
Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
SENORES
₹788.15
7D
0.03%
1Y
n/a
Noile-Immune Biotech
Market Cap: JP¥6.7b
Researches and develops CAR-T cells for cancer immunotherapies.
4893
JP¥155.00
7D
3.3%
1Y
-3.1%
Devyser Diagnostics
Market Cap: SEK 1.8b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 110.00
7D
-1.1%
1Y
-16.7%
Genovis AB (publ.)
Market Cap: SEK 1.4b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 20.80
7D
0.7%
1Y
-25.8%